Cargando…

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	He, Lingfeng, Luo, Libo, Zhu, Hong, Yang, Huan, Zhang, Yilan, Wu, Huan, Sun, Hongfang, Jiang, Feng, Kathera, Chandra S., Liu, Lingjie, Zhuang, Ziheng, Chen, Haoyan, Pan, Feiyan, Hu, Zhigang, Zhang, Jing, Guo, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579339/ https://www.ncbi.nlm.nih.gov/pubmed/28861953 http://dx.doi.org/10.1002/1878-0261.12118

Ejemplares similares

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Interacting partners of FEN1 and its role in the development of anticancer therapeutics
por: Kathera, Chandrasekhar, et al.
Publicado: (2017)

Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression
por: He, Lingfeng, et al.
Publicado: (2016)

RNA G-Quadruplex within the 5′-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress
por: Ma, Ying, et al.
Publicado: (2023)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
por: Yang, Fan, et al.
Publicado: (2022)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2023)

Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
por: Long, Kaili, et al.
Publicado: (2021)

R152C DNA Pol β mutation impairs base excision repair and induces cellular transformation
por: Zhou, Ting, et al.
Publicado: (2016)

Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018)

The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers
por: Chung, Lin, et al.
Publicado: (2014)

Mutation of DNA Polymerase β R137Q Results in Retarded Embryo Development Due to Impaired DNA Base Excision Repair in Mice
por: Pan, Feiyan, et al.
Publicado: (2016)

Functional regulation of FEN1 nuclease and its link to cancer
por: Zheng, Li, et al.
Publicado: (2011)

Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding
por: Guo, Zhigang, et al.
Publicado: (2010)

Revision of the calcareous fen arachnofauna: habitat affinities of the fen-inhabiting spiders
por: Štokmane, Maija, et al.
Publicado: (2018)

Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression
por: Zou, Jiao, et al.
Publicado: (2018)

Yuan Fen 緣份
por: Wong, Annie N.M.
Publicado: (2022)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2014)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

Corrigendum to “Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial”
por: Li, Yi, et al.
Publicado: (2016)

Polη, Polζ and Rev1 together are required for G to T transversion mutations induced by the (+)- and (−)-trans-anti-BPDE-N(2)-dG DNA adducts in yeast cells
por: Zhao, Bo, et al.
Publicado: (2006)

Corrigendum to “Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders” [Redox Biology 32, 2020, 101535]
por: Zhang, Xin, et al.
Publicado: (2021)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Symmetrical dimethylation of H4R3: A bridge linking DNA damage and repair upon oxidative stress
por: Ma, Zhuang, et al.
Publicado: (2020)

Exosomal-miR-1184 derived from mesenchymal stem cells alleviates cisplatin-associated acute kidney injury
por: Zhang, Jinshi, et al.
Publicado: (2022)

Single-molecule characterization of Fen1 and Fen1/PCNA complexes acting on flap substrates
por: Craggs, Timothy D., et al.
Publicado: (2014)

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
por: Rocha, C R R, et al.
Publicado: (2015)

Corrigendum to “Sodium Fluorescein-Guided Resection under the YELLOW 560 nm Surgical Microscope Filter in Malignant Gliomas: Our First 38 Cases Experience”
por: Zhang, Ningning, et al.
Publicado: (2018)

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2022)

FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells
por: Li, Jin‐Li, et al.
Publicado: (2019)

Isolated FeN(4) Sites for Efficient Electrocatalytic CO(2) Reduction
por: Li, Xiaogang, et al.
Publicado: (2020)

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
por: Račkauskas, Rokas, et al.
Publicado: (2023)

Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022)

Are we restoring functional fens? – The outcomes of restoration projects in fens re-analysed with plant functional traits
por: Klimkowska, Agata, et al.
Publicado: (2019)

Hsa-circRNA-G004213 promotes cisplatin sensitivity by regulating miR-513b-5p/PRPF39 in liver cancer
por: Qin, Ling, et al.
Publicado: (2021)

Corrigendum to “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro”
por: Sun, Bishao, et al.
Publicado: (2021)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: Kataoka, Junro, et al.
Publicado: (2017)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

miR-4324 inhibits ovarian cancer progression by targeting FEN1
por: Wu, Haixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t84612l1f2n4meqa264e4o05s1